The evidence consistently identifies several factors that increase risk further: Higher doses (the weight-loss doses of semaglutide and tirzepatide carry higher risk than the lower diabetic doses) Longer duration of treatment Faster rate of weight loss Pre-existing gallstones even asymptomatic ones found on a previous scan Female sex, age over 40, and family history of gallstones (the standard baseline risk factors, amplified by GLP-1 therapy) If several of these apply to you, the risk-benefit balance of your treatment plan is worth a structured discussion
How many Invisalign cases can one orthodontist see without breaking a sweat
A: I am unsure what medication you are taking for weight loss
We present a case of MNTI which was managed successfully with conservative excision (enucleation)
The pill format will likely increase the adoption of GLP-1 medications due to its lower pricing and convenience, with Novo Nordisks Wegovy pill being priced between $149 to $299 per month versus an average price of $1,000 per month for GLP-1 injectables, for example
Modifier 76: Repeat Injection Procedure by Same Provider Modifier 76 is appended to a subsequent unit of CPT code 96372 on the same date when the same provider repeats the injection for a documented clinical reason